About Selecta Biosciences, Inc. (SELB) — Dividend Analysis 2026
Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. The company's lead therapeutic gene therapy program is SEL-302 that is in preclinical stage to improve the treatment of methylmalonic acidemia. It is also developing biologic therapies, such as SEL-212 that is in Phase III clinical trials for the treatment of chronic refractory gout; and product candidates to treat IgA-mediated diseases, including IgA nephropathy, linear IgA bullous dermatitis, IgA pemphigus, and Henoch-Schonlein purpura. In addition, the company is developing gene therapies comprising SEL-313, a product candidate in preclinical stage to treat ornithine transcarbamylase deficiency; SEL-399, a product candidate to evaluate the appropriate dose of ImmTOR in humans to reduce the formation of antibodies to AAV capsids; and products for the treatment of pompe disease, duchenne muscular dystrophy, limb-girdle muscular dystrophy, lysosomal storage disorder, and other autoimmune diseases. Further, it develops tolerogenic therapies to treat primary biliary cholangitis and other autoimmune diseases. The company has license and collaboration agreements with Takeda Pharmaceuticals USA, Inc.; Swedish Orphan Biovitrum; Sarepta Therapeutics, Inc.; Asklepios Biopharmaceutical, Inc.; Massachusetts Institute of Technology; Shenyang Sunshine Pharmaceutical Co., Ltd.; Ginkgo Bioworks Holdings, Inc.; and IGAN Biosciences, Inc. Selecta Biosciences, Inc. was incorporated in 2007 and is headquartered in Watertown, Massachusetts.
Is SELB a good dividend investment in 2026?
SELB offers a 226.96% forward yield with a 50% payout ratio. Strand Safety Score: 15/100 (Critical Risk). The 5-year dividend CAGR of 0% is modest — investors should weigh current income against growth alternatives.
SELB DRIP calculator — what's the difference?
With DRIP on a $10,000 investment over 10 years, your SELB portfolio grows to $12655037939.60M vs $227.1K without reinvestment. This is the compound interest effect in action.
SELB dividend growth history & forecast
SELB has grown its dividend by 0% over the last year and 0% annually over 5 years. At this pace, an investor who holds for 10+ years will see their yield on cost grow substantially above the current 226.96%.
Company generates negative FCF ($-79M) — borrowing to pay dividends
Debt Leverage
0 / 30 pts
0/30
Company not generating EBITDA — debt servicing risk is elevated
Earnings Momentum-0.1B → -0.1B → -0.2B
15 / 30 pts
15/30
Net income grew in the latest year — positive but trend is unconfirmed
OVERALL ASSESSMENT
High risk of dividend cut — weak fundamentals across multiple factors.
STRAND SCORE
15
/100
Strand Safety Score™ is proprietary to DividendFlow. Inputs: FCF, Debt/EBITDA, Net Income from SEC filings via FMP. Not financial advice. N/A for ETFs, pre-revenue companies, and tickers without income statements.
🌍 SELB Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold SELB.
Gross yield
226.96%
Tax rate
15.00%
After-tax yield
192.92%
Real yield (−CPI)
190.12%
Account/Country
Tax Rate
After-tax Yield
Real Yield
$10K Annual Income
🇺🇸 Roth IRA / 401k
0%
226.96%
224.16%
$22,696 / yr
🇺🇸 US Taxable (15%) ✓
15%
192.92%
190.12%
$19,292 / yr
🇺🇸 US Taxable (20%)
20%
181.57%
178.77%
$18,157 / yr
🇬🇧 UK ISA
0%
226.96%
224.16%
$22,696 / yr
🇬🇧 UK Taxable
8.75%
207.10%
204.30%
$20,710 / yr
🇨🇦 TFSA
0%
226.96%
224.16%
$22,696 / yr
🇨🇦 CA Taxable
25%
170.22%
167.42%
$17,022 / yr
🇦🇺 Super (pension)
15%
192.92%
190.12%
$19,292 / yr
🇦🇺 AU Taxable
30%
158.87%
156.07%
$15,887 / yr
🇩🇪 DE Taxable
26.375%
167.10%
164.30%
$16,710 / yr
🇫🇷 FR Taxable
30%
158.87%
156.07%
$15,887 / yr
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 SELB Income Goal & Break-Even
Dividend Break-Even
1yr
Years for dividends to fully repay your SELB investment of $0.88/share (🇺🇸 US Taxable (15%) · 15.00% tax)
$10K invested · 10 Years
Dividends earned (DRIP)
$2831793290.42M
Lost to inflation (2.8% CPI)
−$2.5K
Real purchasing power gain
$2831793290.42M
12-month CPI (US BLS via FMP economic-indicators).
How much do I need to invest in SELB for:
Shares needed
14,118
Capital required
$12,441
Monthly income
$2,000
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 SELB Dividend Payment Schedule
SELB pays quarterly — 4 times per year. Next ex-div: TBD.
Jan
Feb
Mar
💰
Apr
May
Jun
💰
Jul
Aug
Sep
💰
Oct
Nov
Dec
💰
10 shares
$4.25 / payment
$17.00 / year after tax
100 shares
$42.50 / payment
$170.00 / year after tax
1,000 shares
$425.00 / payment
$1700.00 / year after tax
📊 SELB vs Healthcare Benchmarks
How SELB compares to typical Healthcare averages.
Benchmark: Healthcare
Dividend Yield▲+224.16% vs sectorBetter
SELB
226.96%
avg
2.80%
5Y Dividend CAGR▼-6.80% vs sectorBelow avg
SELB
0.00%
avg
6.80%
Payout Ratio▲-5.00% vs sectorBetter
SELB
50.00%
avg
55.00%
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for SELB sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ SELB Insider Activity
No recent SEC filings reported in the last 90 days.
🔬
Financial Health Scores
Altman Z-Score
-3.62
🔴 Distress Zone — elevated dividend cut risk
Safe: >3.0 · Grey: 1.81–3.0 · Distress: <1.81
Piotroski F-Score
3/9
🔴 Weak fundamentals — dividend safety concern
Strong: 7–9 · Moderate: 4–6 · Weak: 0–3
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
📊 About This Data
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the SELB dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →